Intravenous literature: Anon (2012) BET 3: Emergency management of anthracycline extravasation. Emergency Medical Journal. 29(9), p.777-9.
A short cut review was carried out to establish whether intravenous dexrazoxane reduces the risk of tissue necrosis after extravasation of the chemotherapy agent anthracycline. One paper directly addressed the question. The clinical bottom line is that intravenous dexrazoxane appears to be safe and may reduce the risk of tissue necrosis after extravasation of anthracycline.